In person One of our ADS scientists, Welmoet de Winter will represent our team at the upcoming ELRIG Conference, where she will present the research of our team on site-selective screening and fragment-based drug discovery. Her poster: “Site-selective screening: Design, synthesis and application of stable S-adenosylmethionine-based probes for fragment screening against METTL3/14” focuses on the…
Developments in Protein Interaction Analysis (DiPIA 2026)
In person Our colleagues Henri van Son and Ronald Jean-Baptiste will represent ZoBio team at the DIPIA Conference hosted by Cytiva. This event brings together industry peers to share best practices, research, and new applications in the field. The conference is specifically dedicated to surface plasmon resonance (SPR) technology.. Henri and Ronald will present two…
The FAST Way to Chemotype Prioritization
You have just completed a fragment screen and titrated your hits for confirmation. You have 15 chemotypes you want to follow up on, so you set out to find 10 close analogs for each one. Since this is early days, you don’t want to commit to chemistry, so you search for available compounds. After a…
16th Swiss Course on Medicinal Chemistry in Leysin
In person As in previous years, ZoBio is proud to be part of the 16th Swiss Course on Medicinal Chemistry in Leysin! This five-day Medicinal Chemistry School, organized by the Division of Medicinal Chemistry and Chemical Biology of the Swiss Chemical Society , focuses on the most cutting-edge aspects of small molecule drug discovery, highlighting methodologies…